2017. PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS. Voprosy onkologii. 63, 2 (Feb. 2017), 326–328. DOI:https://doi.org/10.37469/0507-3758-2017-63-2-326-328.